Genetic modification: The production of recombinant pharmaceutical proteins in plants
β Scribed by Ma, Julian K.C. (author);Drake, Pascal M.W. (author);Christou, Paul (author)
- Book ID
- 109951731
- Publisher
- Nature Publishing Group
- Year
- 2003
- Tongue
- English
- Weight
- 290 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1471-0056
- DOI
- 10.1038/nrg1177
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This review is based on our recent experience in producing the first commercial recombinant proteins in transgenic plants. We bring forward the issues that have to be considered in the process of selecting and developing a winning transgenic plant production system. From the production point of view
## Abstract Global demand for recombinant proteins has steadily accelerated for the last 20 years. These recombinant proteins have a wide range of important applications, including vaccines and therapeutics for human and animal health, industrial enzymes, new materials and components of novel nanoβ
The advantages and limitations of plant-based systems for the production of recombinant biopharmaceutical proteins are discussed in the context of other host production systems presently available. A novel approach for the purification of recombinant proteins expressed in oilseeds is described that